Showing results (2151-2160 of 2,239) with videos related to

Sort By:
Pageof 224
Cell Death & Disease|July 11, 2018
CD45+CD33lowCD11bdim myeloid-derived suppressor cells suppress CD8+ T cell activity via the IL-6/IL-8-arginase I axis in human gastric cancerFang-Yuan Mao, Yong-Liang Zhao, Yi-Pin Lv, et al.
Frontiers in Immunology|October 20, 2022
PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinomaYu-Min Zhong, Kai Yin, Yu Chen, et al.
Future Oncology (London, England)|January 19, 2023
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS dataParneet Cheema, Byoung Chul Cho, Helano Freitas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II StudyQing Zhou, Lin Wu, Pei Hu, et al.
Translational Lung Cancer Research|February 10, 2023
Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real-world retrospective observational study (CTONG2004-ADV)Chong-Rui Xu, Qixun Chen, Chengzhi Zhou, et al.
Signal Transduction and Targeted Therapy|December 6, 2023
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II studySi-Yang Liu, Song Dong, Xue-Ning Yang, et al.
The Oncologist|April 19, 2019
Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural NetworkChao Zhang, Xing Sun, Kang Dang, et al.
Molecular Oncology|April 20, 2023
Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapyHai-Yan Tu, Kai Yin, Xiaotian Zhao, et al.
The Lancet. Oncology|December 9, 2025
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 studyYi-Long Wu, Yu Yao, Jin-Ji Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor CellsBen-Yuan Jiang, Yang-Si Li, Wei-Bang Guo, et al.
Pageof 224